Possible (enzymatic) routes and biological sites for metabolic reduction of BNP7787, a new protector against cisplatin-induced side-effects.

M. Verschraagen, E. Boven, E Torun, FH Hausheer, WJ van der Vijgh

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)493-502
JournalBiochemical Pharmacology
Volume68
Issue number3
DOIs
Publication statusPublished - 2004

Cite this